Drug distributor McKesson Corp raised its annual profit forecast on Wednesday, driven by increased sales in its U.S.
McKesson Corporation (NYSE: MCK) has released its fiscal 2025 second quarter financial results. Results can be accessed on McKesson’s Investor Relatio ...
Nov. 4 (UPI) --McKesson Medical-Surgical Inc. entered into an agreement with the Labor Department on Monday resolving ...
IRVING, Texas (AP) — IRVING, Texas (AP) — McKesson Corp. (MCK) on Wednesday reported fiscal second-quarter net income of $241 million. The Irving, Texas-based company said it had net income of $1.87 ...
We recently compiled a list of the 10 Best Pharma Stocks To Buy Right Now. In this article, we are going to take a look at ...
Elizabeth Warren seeks scrutiny of deals that would allow drug middlemen McKesson, Cardinal Health, and Cencora to also ...
MCK's second-quarter fiscal 2025 results are likely to reflect the solid display by the U.S. Pharmaceutical and Specialty Solutions segment, driven by higher prescription volume.
Sen. Elizabeth Warren calls on FTC to block medical distributors McKesson (MCK) and Cardinal Health's (MCK) recent deals to ...
In terms of liquidity and interest, the mean open interest for McKesson options trades today is 166.17 with a total volume of ...
Chicago Partners Investment Group LLC increased its stake in shares of McKesson Co. (NYSE:MCK – Free Report) by 17.0% during ...